Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Today's Big Biotech Winner and Loser: Geron and Galena

While Geron Corp. (NASDAQ: GERN  ) saw a big bounce back today after getting crushed last week, making it today's big winner in the biotech space, Galena Biopharma (NASDAQ: GALE  ) took it on the chin from the market, making it the loser of the day.

Shares of Geron came back 23% today, as hope of an FDA clinical hold on its key drug, imetelstat, may prove temporary. The hold was placed on the drug last week, which crushed shares of the stock. In this video, Motley Fool health-care analyst David Williamson looks at a compelling and bullish Seeking Alpha article that argues the case for why the hold might be temporary, but he warns that this is still a binary outcome investment, and that hoping for a pop if the hold is lifted could be more akin to gambling than investing.

While it was a great day for Geron investors, shares of Galena Biopharma took a big hit, down 12% because of SEC concerns regarding allegations of stock pumping. The SEC is investigating the company as well as an outside investor relation firm on the subject. David says he prefers to stay away from companies being scrutinized by the SEC, saying there are less controversial and better places to invest.

So where else can a growth investor look outside of the volatile biotech space?
They said it couldn't be done. But David Gardner has proved them wrong time, and time, and time again with stock returns like 926%, 2,239%, and 4,371%. In fact, just recently one of his favorite stocks became a 100-bagger. And he's ready to do it again. You can uncover his scientific approach to crushing the market and his carefully chosen six picks for ultimate growth instantly, because he's making this premium report free for you today. Click here now for access.

Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On March 19, 2014, at 2:53 PM, AmericanExports wrote:

    You are implying that all imetelstat research is halted. It is my understanding that the Mayo MF trials are still ongoing. It's annoying to see so many knee jerk articles glossing over the facts.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2880836, ~/Articles/ArticleHandler.aspx, 9/2/2015 1:18:03 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

David Williamson

The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...

Today's Market

updated Moments ago Sponsored by:
DOW 16,246.29 187.94 1.17%
S&P 500 1,932.32 18.47 0.97%
NASD 4,694.58 58.48 1.26%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/2/2015 1:01 PM
GALE $1.61 Up +0.03 +1.90%
Galena Biopharma,… CAPS Rating: *
GERN $2.98 Up +0.05 +1.54%
Geron Corp CAPS Rating: ***